(Q41137331)

27 September 2017

title

Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin (English)

1 reference

1 November 2022

0 references

1 reference

1 reference

1 reference

1 November 2022

author name string

J. A. Den Boer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1697419

1 November 2022

H. G. Westenberg

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1697419

1 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1697419

1 November 2022

publication date

1 January 1990

1 reference

full work available at URL

27 September 2017

http://link.springer.com/content/pdf/10.1007/BF02245749.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF02245749/fulltext.html

1 November 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF02245749

1 November 2022

1 reference

1 November 2022

1 reference

27 September 2017

volume

102

1 reference

27 September 2017

issue

1

1 reference

27 September 2017

page(s)

85-94

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02245749

27 September 2017

exact match

0 references

cites work

Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy.

1 reference

https://api.crossref.org/works/10.1007%2FBF02245749

Neuroendocrine studies with fluvoxamine: animal data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245749

Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245749

Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245749

Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245749

Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245749

Review of the animal pharmacology and pharmacokinetics of fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245749

Melatonin and cortisol increase after fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245749

The assessment of anxiety states by rating

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245749

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245749

Possible mechanisms for lactate's induction of panic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245749

Drug plasma levels and platelet 5-HT uptake inhibition during long-term treatment with fluvoxamine or lithium in patients with affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245749

Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans

21 January 2018

1 reference

12 December 2020

Platelet serotonin uptake in panic disorder.

1 reference

12 December 2020

Melatonin in panic disorder.

1 reference

12 December 2020

Behavioral, neuroendocrine, and biochemical effects of 5-hydroxytryptophan administration in panic disorder

1 reference

12 December 2020

Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist

1 reference

12 December 2020

Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro

1 reference

12 December 2020

Initial depression and response to imipramine in agoraphobia

1 reference

12 December 2020

Serotoninergic Agonists Increase Plasma Levels of β-Endorphin and β-Lipotropin in Humans*

1 reference

12 December 2020

Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. A double-blind comparison of zimeldine, imipramine and placebo.

1 reference

12 December 2020

Long-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor Binding

1 reference

12 December 2020

Behavioral inhibition induced by electrical stimulation of the median raphe nucleus of the rat

1 reference

12 December 2020

Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine

1 reference

12 December 2020

Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects

1 reference

12 December 2020

Antidepressants and serotonergic neurotransmission: an integrative review

1 reference

12 December 2020

Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline

1 reference

12 December 2020

Serotonin S2 receptors blockage and generalized anxiety disorders. A double-blind study on ritanserin and lorazepam.

1 reference

12 December 2020

1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.

1 reference

12 December 2020

Tritiated imipramine binding to platelets is decreased in patients with agoraphobia.

1 reference

12 December 2020

DELINEATION OF TWO DRUG-RESPONSIVE ANXIETY SYNDROMES

1 reference

12 December 2020

Treatment of spontaneous panic attacks with chlomipramine

1 reference

12 December 2020

Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo

1 reference

12 December 2020

A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety

1 reference

12 December 2020

Platelet binding studies in panic disorder

1 reference

12 December 2020

Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study.

1 reference

12 December 2020

Brief standard self-rating for phobic patients

1 reference

12 December 2020

The treatment of phobic anxiety by zimelidine.

1 reference

12 December 2020

Chronic effects of fluoxetine, a selective inhibitor of serotonin uptake, on neurotransmitter receptors

1 reference

12 December 2020

Serotonin function in panic disorder: effect of 1-5-hydroxytryptophan in patients and controls.

1 reference

12 December 2020

Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo

1 reference

12 December 2020

Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat.

1 reference

12 December 2020

Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder

1 reference

12 December 2020

The effects of 5-HTP on para-Chlorophenylalanine (p-CPA) attenuation of "conflict" behavior.

1 reference

12 December 2020

The Fear Questionnaire: a validity study.

1 reference

12 December 2020

Anxiety reconceptualized

1 reference

12 December 2020

The relationship of plasma imipramine and N-desmethylimipramine to improvement in agoraphobia.

1 reference

12 December 2020

A pilot study of the effect of the 5-HT-uptake inhibitor, zimelidine, on phobic anxiety.

1 reference

12 December 2020

Pituitary adrenocortical unresponsiveness in lactate-induced panic.

1 reference

12 December 2020

The influence of acute and subchronic administration of various antidepressants on early morning melatonin plasma levels in healthy subjects: increases following fluvoxamine

1 reference

12 December 2020

The effects of chronic ritanserin treatment on sleep and the neuroendocrine response to L-tryptophan

1 reference

12 December 2020

The effects of benzodiazepines and serotonergic manipulations on punished responding

1 reference

12 December 2020

Platelet [3H]imipramine binding in generalized anxiety disorder, panic disorder, and agoraphobia with panic attacks.

1 reference

12 December 2020

Stimulation of beta-endorphin and beta-lipotropin release from the anterior but not the neurointermediate pituitary lobe in the rat after acute administration of serotonin-acting drugs.

1 reference

12 December 2020

The determination of cortisol in human plasma: evaluation and comparison of seven assays

1 reference

12 December 2020

The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam

1 reference

12 December 2020

Platelet [3H]imipramine binding in patients with panic disorder.

1 reference

12 December 2020

A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.

1 reference

12 December 2020

Treatment of phobic states with antidepressants. A retrospective study of 246 patients

1 reference

12 December 2020

Serotonin function in anxiety

series ordinal

12

1 reference

1 November 2022

Molecular Pharmacology

39

27

600

JE Leysen

1985

1 reference

1 November 2022

Identifiers

DOI

10.1007/BF02245749

1 reference

Dimensions Publication ID

27 September 2017

1019498587

0 references

Fatcat ID

release_3uczvnas4ver5liyncsx7o5hm4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3uczvnas4ver5liyncsx7o5hm4

24 November 2022

mapped directly with Wikidata item

1 reference